CJC-1295 No DAC & Ipamorelin Blend – 100 Vials at 50% Off

Product Overview

Revo Peptide is proud to offer the CJC-1295 No DAC & Ipamorelin Blend in a 100-vial bulk configuration at an exclusive 50% discount. Each vial contains a pre-blended combination of 2 mg CJC-1295 No DAC and 2 mg Ipamorelin, totaling 4 mg of active peptide material per unit. This dual-peptide research blend is manufactured to ≥98% purity standards and is intended exclusively for in vitro and preclinical laboratory research. Researchers seeking to buy this research peptide blend online will find Revo Peptide’s bulk offering to be one of the most competitively priced options available without compromising analytical quality.

Peptide Structure & Amino Acid Sequence

This blend combines two structurally distinct peptides within a single lyophilized vial:

• CJC-1295 No DAC — A 30-amino acid growth hormone-releasing hormone (GHRH) analogue with the sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2. It does not incorporate a Drug Affinity Complex (DAC), resulting in a shorter active profile suited to specific research protocols.
• Ipamorelin — A selective pentapeptide ghrelin mimetic with the sequence: H-Aib-His-D-2-Nal-D-Phe-Lys-NH2, recognized in research literature for its selectivity and structural stability.

Both peptides are synthesized using solid-phase peptide synthesis (SPPS) methodology, ensuring consistent chain assembly and high sequence fidelity across all production batches.

Chemical & Physical Characteristics

• CJC-1295 No DAC Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
• CJC-1295 No DAC Molecular Weight: 3,367.79 g/mol
• Ipamorelin Molecular Formula: C₃₈H₄₉N₉O₅
• Ipamorelin Molecular Weight: 711.86 g/mol
• Blend per vial: 2 mg CJC-1295 No DAC + 2 mg Ipamorelin (4 mg total)
• Physical form: White to off-white lyophilized powder
• Solubility: Soluble in aqueous buffers; sterile water recommended for laboratory reconstitution

Purity & Analytical Verification (HPLC & MS)

Every batch of Revo Peptide’s CJC-1295 No DAC & Ipamorelin Blend undergoes rigorous analytical testing prior to release. Purity is confirmed at ≥98% via reverse-phase high-performance liquid chromatography (RP-HPLC). Identity and molecular integrity of both peptide components are independently verified through mass spectrometry (MS), confirming correct molecular weights and ruling out truncated sequences or synthesis by-products. Certificates of Analysis (CoA) are available upon request for each production lot.

Quality Control & Lyophilization Integrity

Following synthesis and purification, the blended peptide material is lyophilized under controlled vacuum and temperature conditions to remove residual moisture and maximize long-term stability. Each vial is sealed under inert atmosphere to prevent oxidative degradation. Revo Peptide’s quality control pipeline includes multi-point inspection covering appearance, reconstitution behavior, and spectral data cross-referencing, ensuring that every vial in this 100-unit order meets the same exacting standard as the first.

Safety, Handling & Laboratory Precautions

This product is a research-grade lyophilized peptide blend intended exclusively for qualified laboratory personnel. Standard laboratory personal protective equipment (PPE) — including nitrile gloves, lab coat, and safety eyewear — should be worn when handling. Peptide powders should be handled in a low-humidity environment to prevent premature moisture absorption. Avoid prolonged exposure to light, heat, or air prior to reconstitution. This material is not classified as hazardous under standard laboratory reagent guidelines; however, all applicable institutional biosafety protocols must be observed.

Reconstitution, Packaging & Storage

Each vial is individually sealed and packaged within the 100-vial bulk shipment. For laboratory reconstitution, sterile water or an appropriate aqueous buffer is recommended — sterile water is available separately through Revo Peptide’s catalog. Lyophilized vials should be stored at −20°C for long-term preservation. Once reconstituted, solutions should be stored at 4°C and used within a timeframe consistent with your laboratory’s established protocols for peptide stability. Do not refreeze reconstituted solutions.

Intended Research Use & Market Positioning

The CJC-1295 No DAC & Ipamorelin Blend is designed for researchers investigating GHRH analogue signaling, ghrelin receptor pharmacology, and related neuroendocrine pathways in controlled preclinical settings. The pre-blended dual-peptide format reduces laboratory preparation time and supports consistent experimental reproducibility across large study cohorts. This bulk 100-vial offering at 50% off makes it one of the most cost-effective research peptide blends for sale in the current market, ideal for institutions running extended or high-throughput research programs.

Ordering, Availability & Fulfillment

Order now directly through Revo Peptide’s secure online store to take advantage of this 50% bulk discount. All orders are processed promptly, with discreet, laboratory-appropriate packaging and tracked shipping. Revo Peptide maintains consistent stock levels to support ongoing research programs without supply interruption. For volume inquiries beyond 100 vials or institutional purchase orders, contact our research sales team directly. This product is available for sale to verified research buyers only.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. CJC-1295 No DAC & Ipamorelin Blend is sold exclusively as a laboratory research reagent. Revo Peptide makes no representations regarding the safety, efficacy, or suitability of this material for use in humans or animals. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international regulations governing the procurement, handling, and use of research peptides. This product is not a drug, supplement, or therapeutic agent and has not been evaluated or approved by any regulatory authority for medical use.